United States v. Willhite , 98 F. App'x 350 ( 2004 )


Menu:
  •                                                        United States Court of Appeals
    Fifth Circuit
    F I L E D
    IN THE UNITED STATES COURT OF APPEALS           May 25, 2004
    FOR THE FIFTH CIRCUIT
    Charles R. Fulbruge III
    Clerk
    No. 03-41391
    Summary Calendar
    UNITED STATES OF AMERICA,
    Plaintiff-Appellee,
    versus
    RICHARD WILLHITE,
    Defendant-Appellant.
    --------------------
    Appeal from the United States District Court
    for the Eastern District of Texas
    USDC No. 9:02-CR-46-1
    --------------------
    Before JONES, BENAVIDES, and CLEMENT, Circuit Judges.
    PER CURIAM:*
    Richard Willhite appeals the sentence imposed upon his
    guilty-plea conviction for conspiracy to defraud the Food and
    Drug Administration (FDA), in violation of 18 U.S.C. § 371, by
    violating 21 U.S.C. §§ 331(a) and 333(a)(2).   He argues that he
    lacked the requisite intent to defraud for his sentence to be
    based on the felony provision in 21 U.S.C. § 333(a)(2) and that
    the count of the indictment to which he pleaded guilty did not
    *
    Pursuant to 5TH CIR. R. 47.5, the court has determined
    that this opinion should not be published and is not precedent
    except under the limited circumstances set forth in 5TH CIR.
    R. 47.5.4.
    No. 03-41391
    -2-
    contain a conspiring-to-defraud-the-United-States allegation and
    therefore differed from the offense for which he was convicted
    and sentenced.
    Under 18 U.S.C. § 371, a defendant may be charged with
    either conspiring to commit an offense against the United States
    or conspiring to defraud the United States or one of its
    agencies.   The penalty provision of 18 U.S.C. § 371 does not
    differentiate between the two types of conspiracies, but rather,
    provides for a maximum term of imprisonment of five years if the
    object of the conspiracy is the commission of a felony.    Count
    one of the indictment, to which Willhite pleaded guilty, charged
    him with conspiring to commit offenses against the United States
    by intentionally violating provisions of the Food, Drug, and
    Cosmetics Act (FDCA), thereby defrauding and misleading the FDA.
    See e.g., United States v. Arlen, 
    947 F.2d 139
    , 143-44 (5th Cir.
    1991).   It contains the intent-to-defraud language with regard to
    both of the underlying offenses in 21 U.S.C. §§ 331(a) and
    333(a)(2), thus making the underlying offenses, i.e., the object
    of the conspiracy, punishable as felonies.   Willhite’s suggestion
    that he never intended to defraud the FDA is disingenuous.     The
    count of the indictment to which he pleaded guilty is replete
    with allegations that he intended to defraud and mislead the FDA
    and there is nothing in the record to suggest otherwise.
    Willhite’s citation to United States v. Haga, 
    821 F.2d 1036
    ,
    1043 (5th Cir. 1987) is unavailing.   Haga was convicted and
    No. 03-41391
    -3-
    sentenced for “‘the felony offense of conspiracy to defraud an
    agency of the United States, the FDA’ under the ‘defraud’ clause
    of section 371,” but he was indicted only under the conspiracy
    “to commit any offense against the United States” clause of
    18 U.S.C. § 371.    
    Id. at 1042,
    1043, 1044-45.   That was not the
    case for Willhite, who was indicted, convicted, and sentenced
    under the “commit any offense against the United States” clause
    of 18 U.S.C. § 371.
    Willhite’s argument that he relied on the advice of counsel
    and was therefore unaware that he was violating the law is
    disingenuous.    The record indicates that Willhite did not
    disclose all relevant information to counsel and that Willhite
    admitted at the sentencing hearing that he knew his actions were
    illegal.
    The Government’s evidence was sufficient to make out a
    violation of 21 U.S.C. § 333(a)(2) because it demonstrated that
    Willhite intentionally violated § 331(a) with the specific intent
    to defraud or mislead the FDA.    See 
    Arlen, 947 F.2d at 143
    .
    AFFIRMED.
    

Document Info

Docket Number: 03-41391

Citation Numbers: 98 F. App'x 350

Judges: Benavides, Clement, Jones, Per Curiam

Filed Date: 5/25/2004

Precedential Status: Non-Precedential

Modified Date: 8/1/2023